Hepatocellular carcinoma treated with sorafenib: authors' reply

被引：0
|
作者：
Peck-Radosavljevic, M. [1 ]
Pinter, M. [1 ]
Sieghart, W. [1 ]
机构：
[1] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 34卷 / 11-12期
关键词：
D O I：
10.1111/j.1365-2036.2011.04889.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1348 / 1349
页数：2
相关论文
共 50 条
  • [21] A comparison of prognostic systems in hepatocellular carcinoma treated with sorafenib.
    Bagnall, Elizabeth Marie
    Gresham, Gillian
    Czaykowski, Piotr
    Chan, Kelvin K.
    Fung, Jennifer
    Cuvelier, Susan
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
    Apostolidis, Leonidas
    Pfeiffenberger, Jan
    Gotthardt, Daniel
    Radeleff, Boris
    Mehrabi, Arianeb
    Schemmer, Peter
    Jaeger, Dirk
    Schirmacher, Peter
    Stremmel, Wolfgang
    Schulze-Bergkamen, Henning
    Springfeld, Christoph
    Weiss, Karl Heinz
    GASTROINTESTINAL TUMORS, 2018, 5 (1-2) : 38 - 46
  • [23] Acute Hepatitis in a Patient With Cirrhosis and Hepatocellular Carcinoma Treated With Sorafenib
    Llanos, Lucia
    Bellot, Pablo
    Zapater, Pedro
    Perez-Mateo, Miguel
    Such, Jose
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (01): : 257 - 258
  • [24] Predictors of time to progression in patients treated with sorafenib for hepatocellular carcinoma
    Salimi, S.
    Mudaliar, S.
    Davison, S.
    Shackel, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 92 - 93
  • [25] Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Biselli, Maurizio
    Reggidori, Nicola
    Iavarone, Massimo
    Renzulli, Matteo
    Lani, Lorenzo
    Granito, Alessandro
    Piscaglia, Fabio
    Lorenzini, Stefania
    Alimenti, Eleonora
    Vara, Giulio
    Caraceni, Paolo
    Sangiovanni, Angelo
    Marignani, Massimo
    Gigante, Elia
    Brandi, Nicolo
    Gramenzi, Annagiulia
    Trevisani, Franco
    CANCERS, 2024, 16 (06)
  • [26] LEVOCARNITINE INHIBITS PRESARCOPENIA IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Nagai, Hidenari
    Amanuma, Makoto
    Mukozu, Takanori
    Kobayashi, Kojiro
    Watanabe, Go
    Ogino, Yu
    Matsui, Teppei
    Daido, Yasuko
    Wakui, Noritaka
    Momiyama, Koichi
    Igarashi, Yoshinori
    HEPATOLOGY, 2021, 74 : 654A - 655A
  • [27] Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
    Ozenne, Violaine
    Paradis, Valerie
    Pernot, Simon
    Castelnau, Corinne
    Vullierme, Marie-Pierre
    Bouattour, Mohamed
    Valla, Dominique
    Farges, Olivier
    Degos, Francoise
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (09) : 1106 - 1110
  • [28] Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
    Sansone, Vito
    Tovoli, Francesco
    Casadei-Gardini, Andrea
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Rimini, Margherita
    Tortora, Raffaella
    Nardi, Elena
    Ielasi, Luca
    Piscaglia, Fabio
    Granito, Alessandro
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [29] Sorafenib in Hepatocellular Carcinoma
    Bajetta, Emilio
    Procopio, Giuseppe
    Colombo, Andrea
    Guadalupi, Valentina
    Verzoni, Elena
    Pietrantonio, Filippo
    Pusceddu, Sara
    Manzoni, Mariangela
    Gevorgyan, Arpine
    Buzzoni, Roberto
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 277 - 287
  • [30] Sorafenib in hepatocellular carcinoma
    Josephs, Debra H.
    Ross, Paul J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (08) : 451 - 456
12345